Deposition of transthyretin is increasingly recognized in valves excised from patients undergoing valve replacement for CAVD (50), and cardiac amyloidosis is increasingly recognized as a comorbidity of CAVD (51). The gene discussed is TTR; the disease is cardiac amyloidosis.